Autus Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$283K Hold
514
0.05% 125
2022
Q3
$261K Sell
514
-5
-1% -$2.8K 0.05% 124
2022
Q2
$282K Buy
519
+16
+3% +$8.81K 0.05% 124
2022
Q1
$297K Sell
503
-59
-10% -$33.9K 0.04% 129
2021
Q4
$375K Buy
562
+10
+2% +$6.24K 0.04% 141
2021
Q3
$315K Hold
552
0.03% 141
2021
Q2
$279K Hold
552
0.03% 148
2021
Q1
$252K Hold
552
0.03% 152
2020
Q4
$257K Hold
552
0.03% 140
2020
Q3
$244K Hold
552
0.03% 144
2020
Q2
$200K Buy
+552
New +$185K 0.03% 152

Other funds holding TMO

Autus Asset Management's TMO Position: Q4 2022 in Review

Autus Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q4 2022 at 514 shares worth $283K. The position accounts for 0.05% of the portfolio, ranked #125.

Autus Asset Management first reported a position in TMO in Q2 2020 and has held it in 11 quarters since. The position peaked at $375K in Q4 2021. 2,376 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Autus Asset Management held 514 shares of Thermo Fisher Scientific worth $283K as of Q4 2022.
  • Autus Asset Management left its Thermo Fisher Scientific share count unchanged in Q4 2022.
  • Thermo Fisher Scientific made up 0.05% of Autus Asset Management's portfolio in Q4 2022, its #125 holding.
  • Autus Asset Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 11 quarters since.
  • Autus Asset Management's Thermo Fisher Scientific position peaked at $375K in Q4 2021.
  • 2,376 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Autus Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.